Update Date: 28.07.2025
Lobular carcinoma in situ is a growth of cells that happens in a milk gland in the breast tissue. The cells undergo changes that make them look different from typical cells. Lobular carcinoma in situ, which is often shortened to LCIS, isn't cancer. But having lobular carcinoma in situ increases the risk of getting breast cancer in the future.
Lobular carcinoma in situ usually isn't found on a mammogram or felt during a breast exam. The condition is most often found after a procedure to remove some breast tissue, such as a breast biopsy or a lumpectomy.
Lobular carcinoma in situ increases the risk of breast cancer in both breasts. If you're diagnosed with lobular carcinoma in situ, you may need increased breast cancer screening. You also may want to consider treatments to reduce your risk of developing invasive breast cancer.
Lobular carcinoma in situ doesn't cause signs or symptoms. It's usually found after a procedure to remove some breast tissue, such as a breast biopsy or a lumpectomy. Lobular carcinoma in situ, also called LCIS, isn't cancer. It's a sign that you have an increased risk of breast cancer in the future.
Make an appointment with a doctor or other healthcare professional if you notice a change in your breasts. Changes may include a lump, an area of puckered or otherwise unusual skin, a thickened region under the skin, and nipple discharge.
Ask when you should consider breast cancer screening and how often it should be repeated. Most healthcare professionals recommend routine breast cancer screening beginning in your 40s.
It's not clear what causes lobular carcinoma in situ, also called LCIS. Lobular carcinoma in situ begins when cells in a milk-producing gland of a breast, called a lobule, develop changes in their DNA. These changes cause the cells to look different from healthy cells. The changed cells remain in the lobule and don't extend into, or invade, nearby breast tissue.
If you have lobular carcinoma in situ, it doesn't mean that you have cancer. But having lobular carcinoma in situ increases your risk of breast cancer and makes it more likely that you may develop invasive breast cancer.
The risk of breast cancer in women diagnosed with lobular carcinoma in situ is thought to be approximately 25% to 30%. For comparison, the risk of developing breast cancer for women in general is thought to be 13%.
Your individual risk of breast cancer is based on many factors. Talk to your healthcare team to better understand your personal risk of breast cancer.
Lobular carcinoma in situ is more common in those who haven't gone through menopause yet.
Lobular carcinoma in situ, also called LCIS, increases the risk of breast cancer. If you're worried about breast cancer, take steps to reduce your risk, such as:
Talk with your doctor or other healthcare professional about when to begin breast cancer screening. Ask about the benefits and risks of screening. Together, you can decide what breast cancer screening tests are right for you.
Breast cancer screening often involves having regular mammograms. If you have a history of lobular carcinoma in situ, talk with your healthcare professional about whether additional imaging tests, such as MRI, might be right for you.
You may choose to become familiar with your breasts by occasionally inspecting them during a breast self-exam for breast awareness. If you find a new change, lumps or other unusual signs in your breasts, tell a healthcare professional right away.
Breast awareness can't prevent breast cancer. But it may help you to better understand the look and feel of your breasts. This might make it more likely that you'll notice if something changes.
If you choose to drink alcohol, limit the amount you drink to no more than one drink a day. For breast cancer prevention, there is no safe amount of alcohol. So if you're very concerned about your breast cancer risk, you may choose to not drink alcohol.
Aim for at least 30 minutes of exercise on most days of the week. If you haven't been active lately, ask your healthcare professional whether exercising is OK and start slowly.
Combination hormone therapy for menopause symptoms may increase the risk of breast cancer. Talk with a healthcare professional about the benefits and risks of hormone therapy.
Some people have symptoms during menopause that cause discomfort. These people may decide that the risks of hormone therapy are acceptable to get relief. To reduce the risk of breast cancer, use the lowest dose of hormone therapy possible for the shortest amount of time.
If your weight is healthy, work to maintain that weight. If you need to lose weight, ask a healthcare professional about healthy ways to lower your weight. Eat fewer calories and slowly increase the amount you exercise.
Lobular carcinoma in situ, also called LCIS, is most often diagnosed during a breast biopsy. A breast biopsy is a procedure to remove a sample of breast tissue for testing. Lobular carcinoma in situ often can't be detected on a mammogram or felt during a breast exam.
Types of breast biopsy that may be used include:
The tissue removed during a biopsy is sent to a lab. In the lab, doctors that specialize in analyzing blood and body tissues, called pathologists, closely examine the cells. They can determine if you have lobular carcinoma in situ.
Treatment for lobular carcinoma in situ, also called LCIS, often involves close monitoring for signs of cancer. Medicines or surgery may be used to lower the risk of breast cancer. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health and your preferences.
If you've been diagnosed with lobular carcinoma in situ, you may need more frequent exams to look for signs of breast cancer. Exams may include:
Medicines that block the hormone estrogen in the body can lower the risk of breast cancer. Most breast cancers use estrogen and other hormones to help the cancer grow. Blocking estrogen helps stop cancer from forming.
Hormone-blocking medicines that are used to lower breast cancer risk include:
These medicines are typically taken daily for five years to reduce the risk of breast cancer. The medicine tamoxifen is sometimes taken in a lower dose every other day. Talk with your healthcare team about which medicine is best for you.
If you have a very high risk of breast cancer, your healthcare team might recommend surgery to lower your risk. Your risk might be high if you have a strong family history of breast cancer. Your risk also may be high if DNA changes that increase the risk of breast cancer run in your family. One operation that can lower the risk of breast cancer is surgery to remove one or both breasts. This procedure is called a risk-reducing mastectomy or a prophylactic mastectomy.
Surgery is often recommended for a specific type of lobular carcinoma in situ called pleomorphic lobular carcinoma in situ. This type is thought to carry a greater risk of breast cancer.
Pleomorphic lobular carcinoma in situ isn't common. Unlike other kinds of lobular carcinoma in situ, it can be seen on a mammogram.
If a biopsy confirms that you have pleomorphic lobular carcinoma in situ, your healthcare team will likely recommend surgery. One option may be an operation to remove the area of concerning cells. This procedure is called a lumpectomy. Another option may be an operation to remove nearly all of the breast tissue. This procedure is called a mastectomy.
To decide which treatment is best for you, your healthcare team considers how much of your breast tissue needs to be removed, the results of your mammogram, whether you have a strong family history of cancer and your age.
Although lobular carcinoma in situ is not cancer, it can cause worry about the increased risk of a future breast cancer. Coping with the diagnosis may mean finding a long-term way to manage any fear and worry.
To help you cope with a diagnosis of lobular carcinoma in situ, also called LCIS, try to:
Ask your healthcare team questions about your lobular carcinoma in situ and what it means for your breast cancer risk. Use this information to research your treatment options.
Look to reputable sources of information, such as the U.S. National Cancer Institute, to find out more. This may make you feel more confident as you make choices about your care.
You may feel anxious before your breast cancer screening exams. Don't let this stop you from going to all of your appointments. Instead, plan ahead and expect that you'll be anxious.
To cope with feeling anxious, spend time doing things you enjoy in the days before your appointment. Spend time with friends or family, or find quiet time for yourself.
Make healthy changes to your lifestyle, so you can feel your best. For instance, choose a healthy diet that focuses on fruits, vegetables and whole grains. Try to be active for 30 minutes most days of the week. Get enough sleep each night so that you wake feeling rested.
Make an appointment with a doctor or other healthcare professional if you notice a lump or any other unusual change in your breasts.
Here's some information to help you get ready for your appointment.
Your time with your healthcare professional is limited. Prepare a list of questions so that you can make the most of your time together. List your questions from most important to least important in case time runs out. For lobular carcinoma in situ, some basic questions to ask include:
In addition to the questions that you've prepared, don't hesitate to ask other questions you think of during your appointment.
Be prepared to answer some questions about your symptoms and your health, such as:
© 2025 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use